Osteomalacia caused by skull base tumors: Report of 2 cases

Neurosurgery

Volumn 69, Issue 1, 2011, Pages

  Uno, Takeshi ^a   Kawai, Kensuke ^a   Kunii, Naoto ^a   Fukumoto, Seiji ^a   Shibahara, Junji ^a   Motoi, Toru ^b   Saito, Nobuhito ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fibroblast growth factor 23; Osteomalacia; Phosphaturic mesenchymal tumor; Skull base tumor

Indexed keywords

CONTRAST MEDIUM; FIBROBLAST GROWTH FACTOR 23; PHOSPHATE; POLYVINYL ALCOHOL;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BONE DESTRUCTION; BONE GRAFT; BRAIN ANGIOGRAPHY; CANCER MORPHOLOGY; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; EAR ARTERY; EXTERNAL AUDITORY CANAL; EXTERNAL CAROTID ARTERY; EYE DISEASE; FASCIA LATA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEG MUSCLE; MALE; MANDIBLE; MENINGEAL ARTERY; MUSCLE WEAKNESS; MUSCULOSKELETAL PAIN; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENIC OSTEOMALACIA; PHOSPHATE BLOOD LEVEL; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN INCISION; SKULL BASE TUMOR; SKULL SURGERY; SUPERFICIAL TEMPORAL ARTERY; SURGICAL APPROACH; TEMPORAL BONE TUMOR; TUMOR VASCULARIZATION; TUMOR VOLUME; WHEELCHAIR;

FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MESENCHYMOMA; MIDDLE AGED; OSTEOMALACIA; SKULL BASE NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79958849290     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31821867f7     Document Type: Article

References (31)

1. Folpe AL, Fanburg-Smith JC, Billings SD, et al. Most osteomalacia- associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 2004;28(1):1-30. (Pubitemid 38031617)
2. Khosravi A, Cutler CM, Kelly MH, et al. Determination of the elimination halflife of fibroblast growth factor-23. J Clin Endocrinol Metab. 2007;92(6):2374-2377. (Pubitemid 46997149)
3. Jan de Beur SM. Tumor-induced osteomalacia. JAMA. 2005;294(10):1260-1267.
4. Nelson AE, Bligh RC, Mirams M, et al. Clinical case seminar: fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. J Clin Endocrinol Metab. 2003;88(9):4088-4094. (Pubitemid 37153703)
5. Imel EA, Peacock M, Pitukcheewanont P, et al. Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab. 2006;91(6):2055-2061. (Pubitemid 43854981)
6. Siegel HJ, Rock MG, Inwards C, Sim FH. Phosphaturic mesenchymal tumor. Orthopedics. 2002;25(11):1279-1281.
7. Shimada T, Mizutani S, Muto T, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A. 2001;98(11):6500-6505. (Pubitemid 32488266)
8. Schapira D, Ben Izhak O, Nachtigal A, et al. Tumor-induced osteomalacia. Semin Arthritis Rheum. 1995;25(1):35-46.
9. Weidner N, Santa Cruz D. Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer. 1987;59(8):1442-1454.
10. Crouzet J, Mimoune H, Beraneck L, Juan LH. Hypophosphatemic osteomalacia with plantar neurilemoma. A review of the literature (100 cases). Rev Rhum Engl Ed. 1995;62(6):463-466.
11. Yoshioka K, Nagata R, Ueda M, et al. Phosphaturic mesenchymal tumor with symptoms related to osteomalacia that appeared one year after tumorectomy. Intern Med. 2006;45(20):1157-1160. (Pubitemid 44773967)
12. Kaylie DM, Jackson CG, Gardner EK. Oncogenic osteomalacia caused by phosphaturic mesenchymal tumor of the temporal bone. Otolaryngol Head Neck Surg. 2006;135(4):653-654. (Pubitemid 44441631)
13. Yamazaki Y, Okazaki R, Shibata M, et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab. 2002;87(11):4957-4960. (Pubitemid 35316332)
14. Olefsky J, Kempson R, Jones H, Reaven G. "Tertiary" hyperparathyroidism and apparent "cure" of vitamin-D-resistant rickets after removal of an ossifying mesenchymal tumor of the pharynx. N Engl J Med. 1972;286(14):740-745.
15. Shimada T, Hasegawa H, Yamazaki Y, et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res. 2004;19(3):429-435. (Pubitemid 38787398)
16. Carpenter TO. Oncogenic osteomalacia - a complex dance of factors. N Engl J Med. 2003;348(17):1705-1708. (Pubitemid 36459478)
17. Reyes-Mugica M, Arnsmeier SL, Backeljauw PF, Persing J, Ellis B, Carpenter TO. Phosphaturic mesenchymal tumor-induced rickets. Pediatr Dev Pathol. 2000;3(1):61-69. (Pubitemid 30013080)
18. Fukumoto S, Martin TJ. Bone as an endocrine organ. Trends Endocrinol Metab. 2009;20(5):230-236.
19. Ungari C, Rocchi G, Rinna C, Agrillo A, Lattanzi A, Pagnoni M. Hypophosphaturic mesenchymal tumor of the ethmoid associated with oncogenic osteomalacia. J Craniofac Surg. 2004;15(3):523-527.
20. Woo VL, Landesberg R, Imel EA, et al. Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108(6):925-932.
21. Stone MD, Quincey C, Hosking DJ. A neuroendocrine cause of oncogenic osteomalacia. J Pathol. 1992;167(2):181-185.
22. Pirola E, Vergani F, Casiraghi P, Leone EB, Guerra P, Sganzerla EP. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the thoracic spine. J Neurosurg Spine. 2009;10(4):329-333.
23. Weiss D, Bar RS, Weidner N, Wener M, Lee F. Oncogenic osteomalacia: strange tumours in strange places. Postgrad Med J. 1985;61(714):349-355. (Pubitemid 15113184)
24. Yu GH, Katz RL, Raymond AK, Gagel RF, Allison A, McCutcheon I. Oncogenous osteomalacia: fine needle aspiration of a neoplasm with a unique endocrinologic presentation. Acta Cytol. 1995;39(4):831-832.
25. Jan de Beur SM, Streeten EA, Civelek AC, et al. Localisation of mesenchymal tumours by somatostatin receptor imaging. Lancet. 2002;359(9308):761-763. (Pubitemid 34215078)
26. Clunie GP, Fox PE, Stamp TC. Four cases of acquired hypophosphataemic ('oncogenic') osteomalacia. Problems of diagnosis, treatment and long-term management. Rheumatology (Oxford). 2000;39(12):1415-1421.
27. Nelson AE, Mason RS, Robinson BG, et al. Diagnosis of a patient with oncogenic osteomalacia using a phosphate uptake bioassay of serum and magnetic resonance imaging. Eur J Endocrinol. 2001;145(4):469-476. (Pubitemid 32927076)
28. Tsujimura T, Sakaguchi K, Aozasa K. Phosphaturic mesenchymal tumor, mixed connective tissue variant (oncogenic osteomalacia). Pathol Int. 1996;46(3):238-241. (Pubitemid 26171398)
29. Fukumoto S, Takeuchi Y, Nagano A, Fujita T. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia. Bone. 1999;25(3):375-377. (Pubitemid 29406065)
30. Reilly PA. The differential diagnosis of generalized pain. Baillieres Best Pract Res Clin Rheumatol. 1999;13(3):391-401. (Pubitemid 30052713)
31. Kawahara N, Sasaki T, Asakage T, et al. Long-term outcome following radical temporal bone resection for lateral skull base malignancies: a neurosurgical perspective. J Neurosurg. 2008;108(3):501-510. (Pubitemid 351357982)